-
3
-
-
0032537990
-
Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1371-1388
-
-
Fisher, B.1
Costantino, J.P.2
Wickerham, D.L.3
Redmond, C.K.4
Kavanah, M.5
Cronin, W.M.6
Vogel, V.7
Robidoux, A.8
Dimitrov, N.9
Atkins, J.10
Daly, M.11
Wieand, S.12
Tan-Chiu, E.13
Ford, L.14
Wolmark, N.15
-
4
-
-
0033575083
-
The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation
-
(1999)
JAMA
, vol.281
, pp. 2189-2197
-
-
Cummings, S.R.1
Eckert, S.2
Krueger, K.A.3
Grady, D.4
Powles, T.J.5
Cauley, J.A.6
Norton, L.7
Nickelsen, T.8
Bjarnason, N.H.9
Morrow, M.10
Lippman, M.E.11
Black, D.12
Glusman, J.E.13
Costa, A.14
Jordan, V.C.15
-
10
-
-
0033536004
-
Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 7077-7082
-
-
Makela, S.1
Savolainen, H.2
Aavik, E.3
Myllarniemi, M.4
Strauss, L.5
Taskinen, E.6
Gustafsson, J.A.7
Hayry, P.8
-
13
-
-
0031043390
-
Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β
-
(1997)
Mol Endocrinol
, vol.11
, pp. 353-365
-
-
Tremblay, G.B.1
Tremblay, A.2
Copeland, N.G.3
Gilbert, D.J.4
Jenkins, N.A.5
Labrie, F.6
Giguere, V.7
-
16
-
-
0344417000
-
Estrogen receptor subtype-selective ligands: Asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetrahydrochrysenes
-
(1999)
J Med Chem
, vol.42
, pp. 2456-2468
-
-
Meyers, M.J.1
Sun, J.2
Carlson, K.E.3
Katzenellenbogen, B.S.4
Katzenellenbogen, J.A.5
-
17
-
-
0033198735
-
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
-
(1999)
EMBO J
, vol.18
, pp. 4608-4618
-
-
Pike, A.C.1
Brzozowski, A.M.2
Hubbard, R.E.3
Bonn, T.4
Thorsell, A.G.5
Engstrom, O.6
Ljunggren, J.7
Gustafsson, J.8
Carlquist, M.9
-
23
-
-
2642544810
-
Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 3999-4004
-
-
Paige, L.A.1
Christensen, D.J.2
Gron, H.3
Norris, J.D.4
Gottlin, E.B.5
Padilla, K.M.6
Chang, C.7
Ballas, L.M.8
Hamilton, P.T.9
McDonnell, D.P.10
Fowlkes, D.M.11
-
24
-
-
0033618510
-
Peptide antagonists of the human estrogen receptor
-
(1999)
Science
, vol.285
, pp. 744-746
-
-
Norris, J.D.1
Paige, L.A.2
Christensen, D.J.3
Chang, C.Y.4
Huacani, M.R.5
Fan, D.6
Hamilton, P.T.7
Fowlkes, D.M.8
McDonnell, D.P.9
-
25
-
-
0033513582
-
Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors alpha and beta
-
(1999)
Mol Cell Biol
, vol.19
, pp. 8226-8239
-
-
Chang, C.1
Norris, J.D.2
Gron, H.3
Paige, L.A.4
Hamilton, P.T.5
Kenan, D.J.6
Fowlkes, D.7
McDonnell, D.P.8
-
26
-
-
0032581614
-
Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, Cp-336156, a diaryltetrahydronaphthalene
-
(1998)
J Med Chem
, vol.41
, pp. 2928-2931
-
-
Rosati, R.L.1
Jardine, P.D.2
Cameron, K.O.3
Thompson, D.D.4
Ke, H.Z.5
Toler, S.M.6
Brown, T.A.7
Pan, L.C.8
Ebbinghaus, C.F.9
Reinhold, A.R.10
Elliott, N.C.11
Newhouse, B.N.12
Tjoa, C.M.13
Sweetnam, P.M.14
Cole, M.J.15
Arriola, D.F.16
Pirie, C.M.17
Qi, H.18
Simmons, H.A.19
Tkalcevic, G.T.20
more..
-
27
-
-
0030741983
-
Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone
-
(1997)
Endocrinology
, vol.138
, pp. 3901-3911
-
-
Willson, T.M.1
Norris, J.D.2
Wagner, B.L.3
Asplin, I.4
Baer, P.5
Brown, H.R.6
Jones, S.A.7
Henke, B.8
Sauls, H.9
Wolfe, S.10
Morris, D.C.11
McDonnell, D.P.12
-
33
-
-
0033305431
-
The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
-
(1999)
Mol Endocrinol
, vol.13
, pp. 1672-1685
-
-
Webb, P.1
Nguyen, P.2
Valentine, C.3
Lopez, G.N.4
Kwok, G.R.5
McInerney, E.6
Katzenellenbogen, B.S.7
Enmark, E.8
Gustafsson, J.A.9
Nilsson, S.10
Kushner, P.J.11
-
39
-
-
84995870933
-
Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
-
(1994)
Mol Endocrinol
, vol.8
, pp. 21-30
-
-
Tzukerman, M.T.1
Esty, A.2
Santiso-Mere, D.3
Danielian, P.4
Parker, M.G.5
Stein, R.B.6
Pike, J.W.7
McDonnell, D.P.8
-
49
-
-
0033347396
-
Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression
-
(1999)
Mol Endocrinol
, vol.13
, pp. 2108-2121
-
-
Szapary, D.1
Huang, Y.2
Simons S.S., Jr.3
-
52
-
-
0030797902
-
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
-
(1997)
Science
, vol.277
, pp. 965-968
-
-
Anzick, S.L.1
Kononen, J.2
Walker, R.L.3
Azorsa, D.O.4
Tanner, M.M.5
Guan, X.-Y.6
Sauter, G.7
Kallioniemi, O.-P.8
Trent, J.M.9
Meltzer, P.S.10
-
54
-
-
11744282298
-
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 2920-2925
-
-
Lavinsky, R.M.1
Jepsen, K.2
Heinzel, T.3
Torchia, J.4
Mullen, T.-M.5
Schiff, R.6
DelRio, A.L.7
Ricote, M.8
Ngo, S.9
Gemsch, J.10
Hilsenbeck, S.G.11
Osborne, C.K.12
Glass, C.K.13
Rosenfeld, M.G.14
Rose, D.W.15
-
56
-
-
0032579292
-
Transcription factor-specific requirements for coactivators and their acetyltransferase functions
-
(1998)
Science
, vol.279
, pp. 703-707
-
-
Korzus, E.1
Torchia, J.2
Rose, D.W.3
Xu, L.4
Kurokawa, R.5
McInerney, E.M.6
Mullen, T.-M.7
Glass, C.K.8
Rosenfeld, M.G.9
-
64
-
-
0033304993
-
The estrogen receptor beta-isoform (ERβ) of the human estrogen receptor modulates ER alpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
-
(1999)
Endocrinology
, vol.140
, pp. 5566-5578
-
-
Hall, J.M.1
McDonnell, D.P.2
-
68
-
-
2642593030
-
The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor
-
(1998)
Cancer Res
, vol.58
, pp. 1872-1875
-
-
Levenson, A.S.1
Jordan, V.C.2
-
72
-
-
0027302009
-
Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1
-
(1993)
Mol Endocrinol
, vol.7
, pp. 743-752
-
-
Aronica, S.M.1
Katzenellenbogen, B.S.2
-
73
-
-
0028300031
-
Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: Antiestrogen-selectivity and promoter-dependence
-
(1994)
Mol Endocrinol
, vol.8
, pp. 296-304
-
-
Fujimoto, N.1
Katzenellenbogen, B.S.2
-
76
-
-
0028886694
-
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
-
(1995)
Science
, vol.270
, pp. 1491-1494
-
-
Kato, S.H.1
Endoh, Y.2
Masuhiro, Y.3
Kitamoto, T.4
Uchiyama, S.5
Sasaki, H.6
Masucshige, S.7
Gotoh, Y.8
Nishida, E.9
Kawashima, H.10
Metzger, D.11
Chambon, P.12
-
77
-
-
0029855010
-
Steroid hormone receptors and their regulation by phosphorylation
-
(1996)
Biochem J
, vol.319
, pp. 657-667
-
-
Weigel, N.L.1
-
94
-
-
0033607306
-
The function of estrogen receptor tyrosine 537 in hormone binding, DNA binding and transactivation
-
(1999)
Biochemistry
, vol.38
, pp. 14146-14156
-
-
Yudt, M.R.1
Vorojeikina, D.2
Zhong, L.3
Skafar, D.F.4
Sasson, S.5
Gasiewicz, T.A.6
Notides, A.C.7
|